ERS GENOMICS
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property. The CRISPR-Cas9 utilizes a molecular complex comprised of the protein Cas9 together with one or more guide RNAs which binds to the genome in living cells at any desired locations and also offers significant advantages in cost, speed, efficiency over the earlier genome editing methods. ERS Genomics was founded in 2014 and is headquartered in Dublin, Ireland.
ERS GENOMICS
Industry:
Biotechnology Intellectual Property
Founded:
2014-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.ersgenomics.com
Total Employee:
1+
Status:
Active
Contact:
+353 1 539-0082
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Employees Featured
Founder
Official Site Inspections
http://www.ersgenomics.com
- Host name: 63.220.178.68.host.secureserver.net
- IP address: 68.178.220.63
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ERS Genomics"
ERS Genomics and IRBM sign CRISPR/Cas9 license …
May 20, 2024 For additional information please visit www.ersgenomics.com. About IRBM www.irbm.com IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, …See details»
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Mar 13, 2024 Tokyo, Japan, and Dublin, Ireland, March 13, 2024: Ricoh Company, Ltd. today announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics …See details»
ERS Genomics - Crunchbase Company Profile & Funding
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property. The CRISPR-Cas9 utilizes a molecular complex comprised of the …See details»
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Mar 13, 2024 ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Non-exclusive …See details»
ERS Genomics and NUVISAN ICB sign CRISPR/Cas9 license …
About ERS Genomics www.ersgenomics.com ERS Genomics is a biotechnology company based in Dublin, Ireland. The company was formed to provide broad ... (CRO) and Contract …See details»
ERS Genomics - LinkedIn
ERS Genomics Biotechnology Research San Francisco, CA 1,467 followers The global CRISPR/Cas9 licensing leaderSee details»
The Global Leader in CRISPR/Cas9 Licensing - ERS Genomics
[email protected] ERS Genomics Ltd 8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland. Title: ERS_3.2.21 Created Date: 1/31/2023 1:22:54 PM ...See details»
Crown Bioscience and ERS Genomics Announce Global …
Dec 8, 2022 Crown Bioscience is a global contract research organization (CRO) supporting drug discovery and development for oncology, immuno-oncology, and immune-mediated …See details»
ERS Genomics Limited ('ERS') completes licensing agreement with …
Oct 18, 2023 ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on CRISPR/Cas9, provides access to …See details»
About ERS and Our CRISPR/Cas9 Credentials | ERS …
Founded in 2014, ERS Genomics is the world's leading provider of access to the proprietary rights to foundational CRISPR/Cas9 patents.See details»
ERS Genomics - Overview, News & Similar companies - ZoomInfo
Who is ERS Genomics. ERS Genomics is a biotechnology company based in Dublin, Ireland. The company was formed to provide broad access to the foundational CRISPR/Cas9 in tellectual …See details»
ERS Genomics Limited ('ERS') completes licensing agreement with …
Oct 19, 2023 ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Development and Manufacturing …See details»
ERS Genomics and GenScript Biotech Corporation Sign …
May 12, 2021 About GenScript Biotech Corporation GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Based on its leading gene synthesis technology, …See details»
ERS Genomics Limited ('ERS') completes licensing agreement with …
Dublin, Ireland – 19/10/2023** - ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Syngene gains access to ERS …See details»
ERS Genomics and GenScript Biotech Corporation sign
May 12, 2021 Dublin, Ireland and Piscataway, New Jersey, 12 May 2021 - ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 …See details»
ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 ...
Aug 10, 2023 License allows Santa Cruz Biotechnology to develop and commercialize products using CRISPR/Cas9. DUBLIN and DALLAS, Aug. 10, 2023 /PRNewswire/ -- ERS Genomics …See details»
ERS Genomics - Craft
ERS Genomics is a company developing and commercializing genome editing technology. It offers a CRISPR-Cas9 platform that utilizes a molecular complex comprised of the protein …See details»
Knowledge Centre and FAQ - ERS Genomics
At ERS Genomics we work with businesses to help them develop and grow, our people have the perspectives to give you the inside track with a range of knowledge and insights across …See details»
CRISPR/Cas9 Genomics, Research & Insights | ERS Genomics
Sep 30, 2024 Get the very latest gene engineering industry news from the principle authority on CRISPR/Cas9 technology, innovation and licensing worldwide.See details»